113 related articles for article (PubMed ID: 19916908)
1. Dermatopontin is expressed in human liver and is downregulated in hepatocellular carcinoma.
Li X; Feng P; Ou J; Luo Z; Dai P; Wei D; Zhang C
Biochemistry (Mosc); 2009 Sep; 74(9):979-85. PubMed ID: 19916908
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling.
Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG
Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533
[TBL] [Abstract][Full Text] [Related]
3. Dermatopontin promotes adhesion, spreading and migration of cardiac fibroblasts in vitro.
Liu X; Meng L; Shi Q; Liu S; Cui C; Hu S; Wei Y
Matrix Biol; 2013 Jan; 32(1):23-31. PubMed ID: 23262218
[TBL] [Abstract][Full Text] [Related]
4. Dermatopontin: a potential predictor for metastasis of human oral cancer.
Yamatoji M; Kasamatsu A; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Int J Cancer; 2012 Jun; 130(12):2903-11. PubMed ID: 21796630
[TBL] [Abstract][Full Text] [Related]
5. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
6. Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression.
Guo Y; Li H; Guan H; Ke W; Liang W; Xiao H; Li Y
Mol Cell Endocrinol; 2019 Jan; 480():122-132. PubMed ID: 30391671
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of dermatopontin and its implications for testicular dysfunction in mice.
Cai J; Liu W; Hao J; Chen M; Li G
Mol Med Rep; 2016 Mar; 13(3):2431-8. PubMed ID: 26861869
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal expression of the dermatopontin gene in zebrafish Danio rerio.
Tan Y; Iimura K; Sato T; Ura K; Takagi Y
Gene; 2013 Mar; 516(2):277-84. PubMed ID: 23266816
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
11. Expression and integrity of dermatopontin in chronic cutaneous wounds: a crucial factor in impaired wound healing.
Krishnaswamy VR; Manikandan M; Munirajan AK; Vijayaraghavan D; Korrapati PS
Cell Tissue Res; 2014 Dec; 358(3):833-41. PubMed ID: 25260909
[TBL] [Abstract][Full Text] [Related]
12. Dermatopontin, a shell matrix protein gene from pearl oyster Pinctada martensii, participates in nacre formation.
Jiao Y; Wang H; Du X; Zhao X; Wang Q; Huang R; Deng Y
Biochem Biophys Res Commun; 2012 Aug; 425(3):679-83. PubMed ID: 22842462
[TBL] [Abstract][Full Text] [Related]
13. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
14. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M
Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
16. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
Lu Y; Wu LQ; Li CS; Wang SG; Han B
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
[TBL] [Abstract][Full Text] [Related]
18. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
[TBL] [Abstract][Full Text] [Related]
19. NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC.
Cao Y; Agarwal R; Dituri F; Lupo L; Trerotoli P; Mancarella S; Winter P; Giannelli G
Cell Death Dis; 2017 Feb; 8(2):e2634. PubMed ID: 28230858
[TBL] [Abstract][Full Text] [Related]
20. Role of dermatopontin in re-epithelialization: implications on keratinocyte migration and proliferation.
Krishnaswamy VR; Korrapati PS
Sci Rep; 2014 Dec; 4():7385. PubMed ID: 25486882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
